Systematic Review of the Diagnostic Criteria and Severity Classification for Fuchs Endothelial Corneal Dystrophy

Scheimpflug原理 医学 分级(工程) 光学相干层析成像 眼科 角膜营养不良 指南 梅德林 验光服务 角膜 病理 政治学 工程类 土木工程 法学
作者
Yoshinori Oie,Takefumi Yamaguchi,Naoshi Nishida,Naoki Okumura,Sayo Maeno,Ryo Kawasaki,Vishal Jhanji,Jun Shimazaki,Kohji Nishida
出处
期刊:Cornea [Lippincott Williams & Wilkins]
卷期号:42 (12): 1590-1600
标识
DOI:10.1097/ico.0000000000003343
摘要

There are no defined diagnostic criteria and severity classification for Fuchs endothelial corneal dystrophy (FECD), which are required for objective standardized assessments. Therefore, we performed a systematic literature review of the current diagnosis and severity classification of FECD.We searched the Ovid MEDLINE and Web of Science databases for studies published until January 13, 2021. We excluded review articles, conference abstracts, editorials, case reports with <5 patients, and letters.Among 468 articles identified, we excluded 173 and 165 articles in the first and second screenings, respectively. Among the 130 included articles, 61 (47%) and 99 (76%) mentioned the diagnostic criteria for FECD and described its severity classification, respectively. Regarding diagnosis, slitlamp microscope alone was the most frequently used device in 31 (51%) of 61 articles. Regarding diagnostic findings, corneal guttae alone was the most common parameter [adopted in 23 articles (38%)]. Regarding severity classification, slitlamp microscopes were used in 88 articles (89%). The original or modified Krachmer grading scale was used in 77 articles (78%), followed by Adami's classification in six (6%). Specular microscopes or Scheimpflug tomography were used in four articles (4%) and anterior segment optical coherence tomography in one (1%).FECD is globally diagnosed by the corneal guttae using slitlamp examination, and its severity is predominantly determined by the original or modified Krachmer grading scale. Objective severity grading using Scheimpflug or anterior segment optical coherence tomography can be applied in the future innovative therapies such as cell injection therapy or novel small molecules.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
0001发布了新的文献求助10
刚刚
华仔应助难度采纳,获得10
刚刚
慈祥的乐菱完成签到 ,获得积分10
1秒前
lc完成签到,获得积分10
1秒前
1秒前
清秋发布了新的文献求助10
1秒前
zxe111完成签到 ,获得积分10
1秒前
心落失完成签到,获得积分10
1秒前
Moonpie应助qq采纳,获得10
1秒前
强砸完成签到,获得积分10
2秒前
浅陌初心完成签到 ,获得积分10
2秒前
PYF8086发布了新的文献求助10
2秒前
jzm发布了新的文献求助10
3秒前
3秒前
wzwz发布了新的文献求助10
3秒前
无极微光应助Fe_采纳,获得20
3秒前
4秒前
柿子发布了新的文献求助10
5秒前
6秒前
6秒前
51区发布了新的文献求助10
7秒前
科研通AI6.1应助karaha采纳,获得10
7秒前
ming发布了新的文献求助10
8秒前
mengdewen发布了新的文献求助10
8秒前
Ava应助Maggie180811采纳,获得10
8秒前
眼睛大的黑猫完成签到,获得积分10
8秒前
大意的语芹完成签到,获得积分10
9秒前
10秒前
10秒前
PYF8086完成签到,获得积分10
10秒前
初景发布了新的文献求助10
10秒前
传奇3应助wzwz采纳,获得10
11秒前
领导范儿应助昏睡的橘子采纳,获得10
11秒前
可爱的函函应助AA采纳,获得10
11秒前
11秒前
Orange应助俊逸书琴采纳,获得10
12秒前
李健的小迷弟应助xzy采纳,获得10
12秒前
Fe_完成签到,获得积分10
12秒前
天天快乐应助陈槊诸采纳,获得10
12秒前
12秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Picture this! Including first nations fiction picture books in school library collections 2000
The Cambridge History of China: Volume 4, Sui and T'ang China, 589–906 AD, Part Two 1500
Cowries - A Guide to the Gastropod Family Cypraeidae 1200
Quality by Design - An Indispensable Approach to Accelerate Biopharmaceutical Product Development 800
ON THE THEORY OF BIRATIONAL BLOWING-UP 666
Signals, Systems, and Signal Processing 610
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 物理 内科学 复合材料 催化作用 物理化学 光电子学 电极 细胞生物学 基因 无机化学
热门帖子
关注 科研通微信公众号,转发送积分 6391360
求助须知:如何正确求助?哪些是违规求助? 8206509
关于积分的说明 17370485
捐赠科研通 5445028
什么是DOI,文献DOI怎么找? 2878736
邀请新用户注册赠送积分活动 1855284
关于科研通互助平台的介绍 1698510